• Our focus
Multispecific yet truly natural antibodies

Taking next generation, multispecific antibody technologies into Alzheimer’s Disease and Antimicrobial Resistance

Taking next generation, multispecific antibody technologies into Alzheimer’s Disease and Antimicrobial Resistance

Who we are
Who we are

Long term pharma and biotech professionals with a track record of leading projects from research into the market

Our antibody development roots go deep

Our focus
Our focus

Multispecific yet natural

Alzheimer’s Disease and Antimicrobial Resistance

CD47 Dual targeting
Our pipeline

Fully human bi- and multi-specific antibodies for the treatment of Alzheimer’s Disease and Antimicrobial Resistant infections

Safe and selective blockade of CD47 on tumors

Looking into the future
Looking into the future

Beyond bispecific antibodies

Beyond bispecific antibodies

previous arrow
next arrow

Terms of Use

discoveric bio group owns the copyright for the entire website. Content may not be used and copied in any other context. All liability claims for any information contained on this website are excluded. Logos and images may vary. Copying, using and modifying the contents of the website, even in part, requires the written consent of discoveric bio group.